Clinical Trials 101 in Pediatric Oncology Patients

Alicia Lenzen*, Natasha Pillay Smiley

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Most children with cancer are enrolled in a clinical trial, as progress is still needed for better treatments and improved prognosis. This can include phase I, II, or III trials, which vary from unknown adverse effects to well-established data. In the emergency department, it is critical to know if a patient is participating in a clinical trial and any known details or complications from the treatment. The present article reviews the fundamental foundation of clinical trial phases, as well as possible adverse effects for patients enrolled on these studies.

Original languageEnglish (US)
Pages (from-to)131-134
Number of pages4
JournalClinical Pediatric Emergency Medicine
Volume19
Issue number2
DOIs
StatePublished - Jun 2018

Keywords

  • adverse effect
  • clinical trial
  • oncology
  • phase

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Emergency Medicine

Fingerprint Dive into the research topics of 'Clinical Trials 101 in Pediatric Oncology Patients'. Together they form a unique fingerprint.

Cite this